Cargando…

BREAst Cancer Personalised NuTrition (BREACPNT): dietary intervention in breast cancer survivors treated with endocrine therapy – a protocol for a randomised clinical trial

INTRODUCTION: Breast cancer survivors treated with adjuvant endocrine therapy commonly experience weight gain, which has been associated with low adherence to therapy and worse breast cancer prognosis. We aim to assess whether a personalised postprandial glucose targeting diet will be beneficial for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rein, Michal Sela, Dadiani, Maya, Godneva, Anastasia, Bakalenik-Gavry, Michal, Morzaev-Sulzbach, Dana, Vachnish, Yaeli, Kolobkov, Dmitry, Lotan-Pompan, maya, Weinberger, Adina, Segal, Eran, Gal-Yam, Einav Nili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680181/ https://www.ncbi.nlm.nih.gov/pubmed/36410828 http://dx.doi.org/10.1136/bmjopen-2022-062498

Ejemplares similares

Gut microbiome modulates the effects of a personalised postprandial-targeting (PPT) diet on cardiometabolic markers: a diet intervention in pre-diabetes
por: Ben-Yacov, Orly, et al.
Publicado: (2023)

Chemotherapy Shifts the Balance in Favor of CD8+ TNFR2+ TILs in Triple-Negative Breast Tumors
por: Baram, Tamir, et al.
Publicado: (2021)

Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial
por: Rein, Michal, et al.
Publicado: (2022)

Impact of dietary interventions on pre-diabetic oral and gut microbiome, metabolites and cytokines
por: Shoer, Saar, et al.
Publicado: (2023)

Influence of ICRF 159 and trition WR 1339 on metastases of a rat epithelioma.
por: Pimm, M. V., et al.
Publicado: (1975)

Core promoter sequence in yeast is a major determinant of expression level
por: Lubliner, Shai, et al.
Publicado: (2015)

Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin
por: Htet, Thaw D, et al.
Publicado: (2020)

ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis
por: Zundelevich, Adi, et al.
Publicado: (2020)

Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis
por: Zundelevich, Adi, et al.
Publicado: (2020)

Systematic Dissection of the Sequence Determinants of Gene 3’ End Mediated Expression Control
por: Shalem, Ophir, et al.
Publicado: (2015)

Molecular dissection of the genetic mechanisms that underlie expression conservation in orthologous yeast ribosomal promoters
por: Zeevi, Danny, et al.
Publicado: (2014)

Large-scale mapping of gene regulatory logic reveals context-dependent repression by transcriptional activators
por: van Dijk, David, et al.
Publicado: (2017)

Breast density measurement for personalised screening
por: Sergeant, JC, et al.
Publicado: (2012)

The Mediterranean Diet and Breast Cancer: A Personalised Approach
por: Shaikh, Amani Al, et al.
Publicado: (2019)

Nomogram for the personalisation of radiotherapy treatments in breast cancer patients
por: Beato Tortajada, Inmaculada, et al.
Publicado: (2021)

mRNA-seq whole transcriptome profiling of fresh frozen versus archived fixed tissues
por: Bossel Ben-Moshe, Noa, et al.
Publicado: (2018)

L-Lactate Promotes Adult Hippocampal Neurogenesis
por: Lev-Vachnish, Yaeli, et al.
Publicado: (2019)

Breast cancer genome heterogeneity: a challenge to personalised medicine?
por: Swanton, Charles, et al.
Publicado: (2011)

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
por: Pashayan, N, et al.
Publicado: (2011)

Personalising clinical pathways in a London breast cancer service
por: Viney, William, et al.
Publicado: (2022)

A Systematic p53 Mutation Library Links Differential Functional Impact to Cancer Mutation Pattern and Evolutionary Conservation
por: Kotler, Eran, et al.
Publicado: (2018)

Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention
por: Buckley, Niamh, et al.
Publicado: (2015)

Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy
por: Adehin, Ayorinde, et al.
Publicado: (2020)

Implementation of automated personalised breast radiotherapy planning techniques with scripting in Raystation
por: Gleeson, Ian, et al.
Publicado: (2023)

Proteomic patterns associated with response to breast cancer neoadjuvant treatment
por: Shenoy, Anjana, et al.
Publicado: (2020)

Modelling Circulating Tumour Cells for Personalised Survival Prediction in Metastatic Breast Cancer
por: Ascolani, Gianluca, et al.
Publicado: (2015)

Personalised Therapies for Metastatic Triple-Negative Breast Cancer: When Target Is Not Everything
por: Capici, Serena, et al.
Publicado: (2022)

Two DNA-encoded strategies for increasing expression with opposing effects on promoter dynamics and transcriptional noise
por: Dadiani, Maya, et al.
Publicado: (2013)

Promoters maintain their relative activity levels under different growth conditions
por: Keren, Leeat, et al.
Publicado: (2013)

Unraveling determinants of transcription factor binding outside the core binding site
por: Levo, Michal, et al.
Publicado: (2015)

Horizon scanning implanted biosensors in personalising breast cancer management: First pilot study of breast cancer patients views
por: Ikegwuonu, Theresa, et al.
Publicado: (2018)

BREAst screening Tailored for HEr (BREATHE)—A study protocol on personalised risk-based breast cancer screening programme
por: Liu, Jenny, et al.
Publicado: (2022)

Psychological impact of providing women with personalised 10-year breast cancer risk estimates
por: French, David P., et al.
Publicado: (2018)

Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women
por: Carleton, Neil, et al.
Publicado: (2022)

ICAM-1 on Breast Cancer Cells Suppresses Lung Metastasis but Is Dispensable for Tumor Growth and Killing by Cytotoxic T Cells
por: Regev, Ofer, et al.
Publicado: (2022)

Cumulative risk of breast cancer screening outcomes according to the presence of previous benign breast disease and family history of breast cancer: supporting personalised screening
por: Román, M, et al.
Publicado: (2017)

Update Breast Cancer 2019 Part 4 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast Cancer
por: Schütz, Florian, et al.
Publicado: (2019)

Update Breast Cancer 2019 Part 5 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies in Patients with Advanced Breast Cancer
por: Welslau, Manfred, et al.
Publicado: (2019)

Breast Cancer: Coordinated Regulation of CCL2 Secretion by Intracellular Glycosaminoglycans and Chemokine Motifs()()
por: Lebel-Haziv, Yaeli, et al.
Publicado: (2014)

Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry
por: Shachar, Shlomit S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tvg7kdaudbik6ucr0nat3qvf7a